Richard Metz

4.8k total citations · 1 hit paper
47 papers, 3.4k citations indexed

About

Richard Metz is a scholar working on Biological Psychiatry, Molecular Biology and Oncology. According to data from OpenAlex, Richard Metz has authored 47 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Biological Psychiatry, 14 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Richard Metz's work include Tryptophan and brain disorders (20 papers), Stress Responses and Cortisol (7 papers) and Immune Cell Function and Interaction (7 papers). Richard Metz is often cited by papers focused on Tryptophan and brain disorders (20 papers), Stress Responses and Cortisol (7 papers) and Immune Cell Function and Interaction (7 papers). Richard Metz collaborates with scholars based in United States, Germany and Switzerland. Richard Metz's co-authors include George C. Prendergast, Alexander J. Muller, James B. DuHadaway, Lisa D. Laury‐Kleintop, Laura Mandik‐Nayak, Courtney Smith, David H. Munn, Mario R. Mautino, Andrew L. Mellor and Uma Kamasani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Richard Metz

46 papers receiving 3.3k citations

Hit Papers

Indoleamine 2,3-dioxygenase pathways of pathogenic inflam... 2014 2026 2018 2022 2014 100 200 300

Peers

Richard Metz
Saskia Trump Germany
Martina Ott United States
James B. DuHadaway United States
Richard E. Kast United States
R. Kido Japan
Richard Metz
Citations per year, relative to Richard Metz Richard Metz (= 1×) peers Peter Terness

Countries citing papers authored by Richard Metz

Since Specialization
Citations

This map shows the geographic impact of Richard Metz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Metz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Metz more than expected).

Fields of papers citing papers by Richard Metz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Metz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Metz. The network helps show where Richard Metz may publish in the future.

Co-authorship network of co-authors of Richard Metz

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Metz. A scholar is included among the top collaborators of Richard Metz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Metz. Richard Metz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Seema R., Ian B. Copland, Marco Garcia, Richard Metz, & Jacques Galipeau. (2015). Human mesenchymal stromal cells suppress T-cell proliferation independent of heme oxygenase-1. Cytotherapy. 17(4). 382–391. 9 indexed citations
2.
Prendergast, George C., Richard Metz, Alexander J. Muller, Lauren M.F. Merlo, & Laura Mandik‐Nayak. (2014). IDO2 in Immunomodulation and Autoimmune Disease. Frontiers in Immunology. 5. 585–585. 109 indexed citations
3.
Prendergast, George C., Courtney Smith, Sunil Thomas, et al.. (2014). Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer. Cancer Immunology Immunotherapy. 63(7). 721–735. 398 indexed citations breakdown →
4.
Merlo, Lauren M.F., Elizabeth Pigott, James B. DuHadaway, et al.. (2014). IDO2 Is a Critical Mediator of Autoantibody Production and Inflammatory Pathogenesis in a Mouse Model of Autoimmune Arthritis. The Journal of Immunology. 192(5). 2082–2090. 99 indexed citations
5.
Eldredge-Hindy, Harriet, Albert S. DeNittis, James B. DuHadaway, et al.. (2013). Concurrent whole brain radiotherapy and short-course chloroquine in patients with brain metastases: a pilot trial. Journal of Radiation Oncology. 2(3). 315–321. 51 indexed citations
6.
Smith, Courtney, Mee Young Chang, Katherine H. Parker, et al.. (2012). IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development. Cancer Discovery. 2(8). 722–735. 260 indexed citations
7.
Prendergast, George C. & Richard Metz. (2012). A perspective on new immune adjuvant principles. OncoImmunology. 1(6). 924–929. 11 indexed citations
8.
Chang, Mee Young, et al.. (2011). Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases. Current Medicinal Chemistry. 18(15). 2257–2262. 82 indexed citations
9.
Muller, Alexander J., et al.. (2010). Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth with Ethyl Pyruvate. Cancer Research. 70(5). 1845–1853. 52 indexed citations
10.
Metz, Richard, James B. DuHadaway, Sonja Rust, et al.. (2010). Zinc Protoporphyrin IX Stimulates Tumor Immunity by Disrupting the Immunosuppressive Enzyme Indoleamine 2,3-Dioxygenase. Molecular Cancer Therapeutics. 9(6). 1864–1871. 27 indexed citations
11.
Ciorba, Matthew A., Keely G. McDonald, Richard Metz, et al.. (2010). Induction of IDO-1 by Immunostimulatory DNA Limits Severity of Experimental Colitis. The Journal of Immunology. 184(7). 3907–3916. 81 indexed citations
12.
Prendergast, George C., Richard Metz, & Alexander J. Muller. (2010). Towards a Genetic Definition of Cancer-Associated Inflammation. American Journal Of Pathology. 176(5). 2082–2087. 59 indexed citations
13.
Witkiewicz, Agnieszka K., Christina L. Costantino, Richard Metz, et al.. (2009). Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target. Journal of the American College of Surgeons. 208(5). 781–787. 102 indexed citations
14.
Metz, Richard, James B. DuHadaway, Uma Kamasani, et al.. (2007). Novel Tryptophan Catabolic Enzyme IDO2 Is the Preferred Biochemical Target of the Antitumor Indoleamine 2,3-Dioxygenase Inhibitory Compound d -1-Methyl-Tryptophan. Cancer Research. 67(15). 7082–7087. 387 indexed citations
15.
Chen, Zongyu, Phillip Wong, Lance B. Augustin, et al.. (2001). Mitochondria Isolated from Liver Contain the Essential Factors Required for RNA/DNA Oligonucleotide- Targeted Gene Repair. Biochemical and Biophysical Research Communications. 285(2). 188–194. 31 indexed citations
16.
Vergin, H, et al.. (1995). Pharmacokinetics and bioavailability of different formulations of aciclovir.. PubMed. 45(4). 508–15. 35 indexed citations
17.
Sörgel, F., et al.. (1988). Metabolism of fleroxacin in man. Journal of Antimicrobial Chemotherapy. 22(Supplement_D). 169–178. 20 indexed citations
18.
Naber, Kurt G., et al.. (1988). In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue. Journal of Antimicrobial Chemotherapy. 22(Supplement_D). 199–207. 29 indexed citations
19.
Sörgel, F., et al.. (1988). Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers. Journal of Antimicrobial Chemotherapy. 22(Supplement_D). 155–167. 34 indexed citations
20.
Metz, Richard & Werner Seeger. (1969). Collagen Wrapping of Nerve Homotransplants in Dogs. A preliminary report. European Surgical Research. 1(2). 157–160. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026